IP Library Granted Patent US 9,447,450
Granted Patent B2
US 9,447,450 · App. 14/200,563 · Granted Sep 20, 2016

Red-shifted luciferins and methods of using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,450
App. No.
14/200,563
Granted
Sep 20, 2016
Kind
B2
Abstract

Novel red-shifted luciferin derivatives and uses of those compounds are provided.

Claims (59)

1. A compound according to Formula (Ia):

wherein

X is CN or

each Y is independently halo, SO 3 H, C 1-4 alkyl, substituted C 1-4 alkyl, OR 1 or NR 1 R 2 ;

each R 1 is H, C 1-10 alkyl or substituted C 1-10 alkyl;

each R 2 is H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a 4 to 8 membered ring; and

n is 1 to 6.

2. A compound according to claim 1 , wherein at least one Y is OH.

3. A compound according to claim 1 , wherein at least one Y is NR 1 R 2 .

4. A compound according to claim 1 , wherein at least one Y is OH or NR 1 R 2 and up to 5 additional Ys are halo groups.

5. A compound according to claim 4 , wherein the halo groups are fluoro.

6. A compound according to claim 4 , wherein the halo groups are chloro.

7. A compound according to claim 1 , wherein at least one Y is SO 3 H.

8. A compound according to claim 1 , wherein the compound is a compound of Formula (II):

wherein

X is CN or

Y is OR 1 or NR 1 R 2 ;

R 1 is H, C 1-10 alkyl or substituted C 1-10 alkyl; and

R 2 is H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a ring.

9. A compound according to claim 1 , wherein the compound is a compound of Formula (III):

wherein

X is CN or

Y is OR 1 or NR 1 R 2 ;

R 1 is H, C 1-10 alkyl or substituted C 1-10 alkyl; and

R 2 is H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a ring.

10. A compound according to claim 1 , wherein the compound is a compound of Formula (VII):

wherein

X is CN or

each Y is independently OR 1 or NR 1 R 2 ;

each R 1 is independently H, C 1-10 alkyl or substituted C 1-10 alkyl; and

each R 2 is independently H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a ring.

11. A compound according claim 1 , wherein X is CN.

12. A compound according to claim 1 , wherein X is

13. A compound according to claim 1 , wherein Y is NH 2 .

14. A method for detecting luminescence in a sample comprising

contacting a sample with a compound according to claim 1 ;

contacting the sample with a luciferase, if it is not present in the sample; and

detecting luminescence.

15. The method of claim 14 , wherein the sample contains live cells.

16. The method of claim 14 , wherein the sample contains a luciferase.

17. A method for detecting luminescence in a transgenic animal comprising

administering a compound according to claim 1 to a transgenic animal; and

detecting luminescence;

wherein the transgenic animal expresses a luciferase.

18. A kit comprising a compound according to claim 1 .

19. The kit of claim 18 further comprising a luciferase.

20. The kit of claim 18 further comprising a buffer reagent.

21. A compound selected from the group consisting of:

22. A compound according to claim 1 , wherein the compound is a compound of Formula (VI):

wherein

X is CN or

Y is OR 1 or NR 1 R 2 ;

R 1 is H, C 1-10 alkyl or substituted C 1-10 alkyl; and

R 2 is H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a ring.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2014
From: HITKO, CAROLYN WOODROOFE
To: PROMEGA CORPORATION
Reel/Frame 032504/0626 →